-
Article
Open AccessProgression analysis versus traditional methods to quantify slowing of disease progression in Alzheimer’s disease
The clinical meaningfulness of the effects of recently approved disease-modifying treatments (DMT) in Alzheimer’s disease is under debate. Available evidence is limited to short-term effects on clinical rating...
-
Article
Open AccessDisease severity and mortality in Alzheimer's disease: an analysis using the U.S. National Alzheimer’s Coordinating Center Uniform Data Set
Evidence on the relative risk of death across all stages of Alzheimer’s disease (AD) is lacking but greatly needed for the evaluation of new interventions. We used data from the Uniform Data Set (UDS) of the N...
-
Article
Open AccessObtaining EQ-5D-5L utilities from the disease specific quality of life Alzheimer’s disease scale: development and results from a map** study
The Quality of Life Alzheimer’s Disease Scale (QoL-AD) is commonly used to assess disease specific health-related quality of life (HRQoL) as rated by patients and their carers. For cost-effectiveness analyses,...
-
Article
Open AccessHealth-related quality of life in people with predementia Alzheimer’s disease, mild cognitive impairment or dementia measured with preference-based instruments: a systematic literature review
Obtaining reliable estimates of the health-related quality of life (HR-QoL) of people with predementia Alzheimer’s disease [AD] (preclinical or prodromal AD), mild cognitive impairment (MCI) and dementia is es...
-
Article
Open AccessErratum to: The societal costs of dementia in Sweden 2012 – relevance and methodological challenges in valuing informal care
-
Article
Open AccessThe societal costs of dementia in Sweden 2012 – relevance and methodological challenges in valuing informal care
In this study, we sought to estimate the societal cost of illness in dementia in Sweden in 2012 using different costing approaches to highlight methodological issues.
-
Chapter
‘I Am Different, But I’m Like Everyone Else’: The Dynamics of Disability Identity
The relationship between disability and identity is a debated question in disability research. In this chapter, we would like to contribute to this discussion by drawing on studies of self-identifications and ...
-
Article
Disease progression and costs of care in Alzheimer’s disease patients treated with donepezil: a longitudinal naturalistic cohort
Improved data and methods are needed for modeling disease progression in Alzheimer’s disease (AD) for economic evaluation of treatments. The aim is to estimate prediction models for long-term AD progression an...
-
Article
Alternatief voor een klinische opname
Dit artikel vormt het vervolg op een eerder artikel in Kind en Adolescent Praktijk (Den Teuling, 2011), dat een Zweedse methodiek beschrijft om klinische opnames bij ernstige psychiatrische stoornissen te voor...
-
Article
Differences in resource use and costs of dementia care between European countries: Baseline data from the ictus study
This study aimed to estimate the costs of formal and informal care of patients with Alzheimer's disease, to compare care costs across European countries and identify potential differences in cost patterns betw...
-
Article
IPECAD5 — Fifth International Pharmaco-Economic Conference on Alzheimer’s Disease
The Fifth International Pharmaco-Economic Conference on Alzheimer’s Disease was held in New York, on March 27–29 in 2008. The attendees included researchers and key opinion leaders within the academia, pharmac...
